investigators
[용어속성] Term
Perceptions, Knowledge, and Behaviors Related to COVID-19 Among Social Media Users: Cross-Sectional Study
Original Paper
[키워드] age
Analysis
Behavior
Care
Cohort
conducted
Course
COVID-19
COVID-19 symptoms
cross-sectional
deficiency
determine
Effect
effort
females
Gender
Health
Health Education
health information
identify
information
Instagram
investigators
knowledge
likelihood
males
measure
Measures
media
objective
older subjects
outcome
Perception
platform
Protective
public health
reported
Result
social media
Study design
subgroup analysis
subject
symptoms of COVID-19
the disease
vaccination against COVID-19
virus
washing
WhatsApp
World Health Organization
younger subject
[DOI] 10.2196/19913 PMC 바로가기 [Article Type] Original Paper
[DOI] 10.2196/19913 PMC 바로가기 [Article Type] Original Paper
The COVIRL002 Trial-Tocilizumab for management of severe, non-critical COVID-19 infection: A structured summary of a study protocol for a randomised controlled trial
Letter
[키워드] 1:1
48 hours
absence
Admission
all-cause mortality
Arm
blinded
chest imaging
clinical
commenced
Confirmed
COVID-19
criteria
CRP
D-dimer
Data analysis
database
death
defined
demonstrated
determine
disease
dissemination
dose
Efficacy
element
eligible participant
enrolled
EudraCT
Evidence
evidence of
evidenced
facilitate
ferritin
fibrinogen
hospital
humanized monoclonal antibody
hyper-inflammation
IL-6
IL6
immunology
independent
Infection
inflammatory state
infused
inhibit
interleukin-6
intravenous tocilizumab
intubation
investigators
Ireland
LDH
low dose
management
Mater
moderate to severe
multicentre
non-invasive ventilation
number
objective
Older
open label
outcome
PaO
participant
Patient
patients with COVID-19
PCR-confirmed COVID-19
performed
positive PCR
Potential treatment
primary endpoint
Primary outcome
progression
protocol
pulmonary
randomisation
randomised
randomised controlled trial
Randomised trial
receive
recruited
reduced
Registered
reported
Respiratory failure
Respiratory function
Sample size
SARS-CoV2 infection
single dose
Stage
stage 2
Standard
Standard dose
status
Study protocol
subject
subjects
subsequent
systemic inflammation
target
temperature
Therapeutics
Tocilizumab
treatment group
Trial
ULN
university
Ventilation
website
[DOI] 10.1186/s13063-020-04680-w PMC 바로가기 [Article Type] Letter
[DOI] 10.1186/s13063-020-04680-w PMC 바로가기 [Article Type] Letter
The effect of prostacyclin (Iloprost) infusion at a dose of 1 ng/kg/min for 72 hours compared to placebo in mechanically ventilated patients with COVID-19: A structured summary of a study protocol for a randomized controlled trial
인공호흡기를 사용하는 COVID-19 환자에서 위약과 비교하여 72시간 동안 1ng/kg/min 용량의 프로스타사이클린(일로프로스트) 주입 효과: 무작위 대조 시험을 위한 연구 프로토콜의 구조화된 요약
Letter
[키워드] (Iloprost
(normal saline)
1:1
Acute coronary syndrome
Adult patient
Adult patients
age
anticipated
Biomarker
bleeding
blinded
Blinding
block
can not
Capital
Capital Region
capture
Clinicians
comparator
concealed
conducted
Confirmed
Confirmed COVID-19 infection
Consent
coronary syndrome
COVID-19
COVID-19 infection
COVID-19 patients
criteria
Day
defined
Denmark
dissemination
dose
element
endothelial
endotheliopathy
EudraCT
exclusion criteria
exploratory
facilitate
FIVE
heart failure
Hvidovre Hospital
hypersensitivity
Iloprost
intensive care unit
intensive care units
investigators
Local
mechanical ventilation
mechanically ventilated
mechanically ventilated COVID-19 patients
mechanically ventilated patient
multicenter
normal saline
number
objective
outcome
parallel group
participant
Patient
patients
performed
Placebo
Pregnancy
primary endpoint
prostacyclin
protocol
randomisation
randomised
Randomized
Randomized controlled trial
recruitment
REDCap
Region
Sample size
sequence
statisticians
status
stratified
Study protocol
Suspected
thrombomodulin
total sample size
Trial
Urine
website
Withdrawal
[DOI] 10.1186/s13063-020-04696-2 PMC 바로가기 [Article Type] Letter
[DOI] 10.1186/s13063-020-04696-2 PMC 바로가기 [Article Type] Letter
Effect of an E-Learning Module on Personal Protective Equipment Proficiency Among Prehospital Personnel: Web-Based Randomized Controlled Trial
병원 전 직원의 개인 보호 장비 숙련도에 대한 E-Learning 모듈의 효과: 웹 기반 무작위 대조 시험
Original Paper
[키워드] added
All participant
All participants
baseline
both groups
Care
communication
confidence
Contamination
control group
Controlled
coronavirus
coronavirus disease
COVID-19
demonstration
donning sequence
e-learning group
e-learning module
Effect
effective
effective communication
electronic learning
eligible
email
equipment
evaluate
for inclusion
gamified
gamified e-learning module
groups
Health
Health care
IMPROVE
in both group
infection control
Infection control guidelines
Intervention
investigators
IQR
knowledge
misuse
module
no significant difference
objective
online learning
outcome assessors
pandemic
participant
Participants
Personal protective equipment
PPE
prehospital
preintervention
proportion
protection
Randomized
Randomized controlled trial
Result
risk
Safety
second set
shown
significantly
statistically significant
Switzerland
the median
Trial
web-based study
Work environment
[DOI] 10.2196/21265 PMC 바로가기 [Article Type] Original Paper
[DOI] 10.2196/21265 PMC 바로가기 [Article Type] Original Paper
Cardiac injury associated with severe disease or ICU admission and death in hospitalized patients with COVID-19: a meta-analysis and systematic review
Research
[키워드] 95% CI
Abstract
Admission
Analysis
arrhythmia
article
Biomarker
Biomarkers
cardiac injury
Chinese
CK-MB
CNKI
Cochrane Library
coronavirus disease
COVID-19
COVID-19 patient
database
death
elevated
higher risk
hospitalized patient
ICU
ICU admission
IL-6
IL-6 level
IL-6 levels
independent predictor
individuals
Infrastructure
Injury
intensive care
interleukin-6
investigator
investigators
lactate dehydrogenase
LDH
medRxiv
Meta-analysis
Mortality
Myocardial
Patient
Prognosis
proportion
Result
risk
searched
severe disease
significantly higher
significantly increased
systematic review
TnI
troponin I
[DOI] 10.1186/s13054-020-03183-z PMC 바로가기 [Article Type] Research
[DOI] 10.1186/s13054-020-03183-z PMC 바로가기 [Article Type] Research
Test and treat COVID 65 plus – Hydroxychloroquine versus placebo in early ambulatory diagnosis and treatment of older patients with COVID19: A structured summary of a study protocol for a randomised controlled trial
Letter
[키워드] adaptive
adhere
age
ambulatory
anticipated
blinded
block randomization
calculated
cardiac
Care
Complete
concerning
COVID
COVID-19
COVID-19 disease
cumulative
death
defined
Diagnosis
disease
dissemination
dose
double blind
double-blind
early treatment
elderly patients
element
female patient
first dose
first stage
hospital
Hospitalization
Hydroxychloroquine
identify
Inclusion
interim analysis
investigators
Mental
Mild
moderate
moderate disease
number
objective
older patient
outcome
Outpatient
participant
Patient
patients
PCR
physician
Placebo
placebo-controlled
positive
produced
protocol
provided
randomised
randomised controlled trial
randomization
randomization list
Randomly
Rate
recruited
respiratory rate
risk
Sample size
SARS-CoV2
Septic shock
Side effects
SpO2
status
stratified
study inclusion
Study protocol
study visit
Symptom
symptom onset
Test
throat swab
Total
total sample size
treat
Treatment
Trial
Tübingen
Ulm
website
with COVID-19
[DOI] 10.1186/s13063-020-04556-z PMC 바로가기 [Article Type] Letter
[DOI] 10.1186/s13063-020-04556-z PMC 바로가기 [Article Type] Letter
Global academic response to COVID ‐19: Cross‐sectional study
Original Article
[키워드] characterized
coronavirus
COVID
COVID‐19
Data sharing
dissemination
early stage
editorial
eligible
investigator
investigators
MERS
Middle East
MOST
open‐access
pandemic
Research
SARS‐CoV‐2
syndrome
the disease
to define
Volume
[DOI] 10.1002/leap.1317 PMC 바로가기 [Article Type] Original Article
[DOI] 10.1002/leap.1317 PMC 바로가기 [Article Type] Original Article
Survey Says: “COVID-19 Lockdown Hits Young Faculty and Clinical Trials”
Commentary
[키워드] “COVID-19
Cell
clinical
clinical trial
Community
COVID-19
faculty
impacted
investigators
Laboratory
Research
researcher
Society
STEM
Support
survey
[DOI] 10.1016/j.stemcr.2020.06.010 PMC 바로가기 [Article Type] Commentary
[DOI] 10.1016/j.stemcr.2020.06.010 PMC 바로가기 [Article Type] Commentary
Safety and efficacy assessment of allogeneic human dental pulp stem cells to treat patients with severe COVID-19: structured summary of a study protocol for a randomized controlled trial (Phase I / II)
중증 COVID-19 환자를 치료하기 위한 동종 인간 치수 줄기세포의 안전성 및 효능 평가: 무작위 대조 시험(I/II상)을 위한 연구 프로토콜의 구조화된 요약
Letter
[키워드] 1:1
Acidic
Adenovirus
Admission
AIDS
Alanine
alanine aminotransferase
albumin
alkaline phosphatase
Allogeneic
allogeneic human dental pulp stem cells
amyloid
Analysis
anion gap
Arm ratio
aspartate
Aspartate aminotransferase
average
B lymphocyte
basophils
Before menopause
Bilirubin
blind
blinded
Block randomization method
Blood
blood cell
Blood cells
blood pressure
Blood routine
C-reactive protein
calcium
carbon dioxide
Care
CAST
caused
Cell
cell suspension
change
chest X-ray
Child Pugh score
chlorine
cholesterol
cholinesterase
CLARITY
clinical
Clinical improvement
clinical trial
coded
Coefficient of variation
color
commenced
comparator
computer
Concentration
Consent
consent form
Continuous renal replacement therapy
control group
control groups
COVID-19
COVID-19; randomised controlled trial; protocol; human dental pulp stem cells; dental stem cell banking
COVID-2019
creatine
creatine kinase
creatinine
criteria
crystal
Cytokines
cytomegalovirus
cytomegalovirus CMV-IgG
cytomegalovirus CMV-IgM
Definition
dental pulp
dental pulp stem cells
description
detect
Diastolic blood pressure
direct bilirubin
discharge
disease
dissemination
distress
distribution
DPSCs
ECMO
Efficacy
element
enrolled
eosinophil
eosinophils
epithelial cells
estimated glomerular filtration rate
Estrogen
examined
excluded
exclusion criteria
experimental group
fat globules
Female patients
female subject
filtration rate
Final
flow cytometry
follow-up period
fungi
fungus
Globulin
glomerular filtration rate
Glucose
GRADE
Grade 1
grade 3
Grade 5
granulocyte
HBcAb
HBeAb
HBeAg
HBsAb
HBsAg
hDPSCs
Health Organization
heart rate
hematocrit
Hemodialysis
hemoglobin
hepatitis B
hepatitis C
HFNC
high density lipoprotein
hospitalised patient
Hospitalised patients
Hospitalization
Hospitalized
human DPSC
human DPSCs
hypersensitive C-reactive protein
hypoxia
Identifier
IgA
IgG
IgM
Il -10
IL-1
IL-1 β
IL-2
IL-4
IL-6
immune
Immunoglobulin
Immunological testing
improvement
IMV
inclusion criteria
Infectious disease
Influenza
Influenza virus
informed consent form
injection
Injections
intensive care
intensive care unit
Intravenous injection
Invasive mechanical ventilation
investigator
investigators
ITN-γ
ketone
ketone bodies
Kidney function
Kidney function tests
Killer cell
Laboratory
laboratory examinations
Lactate
lactate dehydrogenase
lactating women
leukocyte
leukocyte enzymes
lipoprotein
lipoprotein A
lipoprotein cholesterol
low density lipoprotein
lung lesion
lung lesions
lymphocyte
Lymphocytes
Macrophage
Magnesium
Medical care
Menopause
Monocytes
mononuclear cell
mononuclear cells
nasal
nasal catheter
natural killer
natural killer cell
neutrophil
Neutrophils
nitrite
NIV
Non-invasive
non-invasive mechanical ventilation
non-squamous epithelial cell
non-squamous epithelial cells
nucleic acid
nucleic acid test
number
objective
observation
occult
occult blood
Other
Other condition
outcome
oxygen
oxygen saturation
parallel group
parasites
partial pressure
participant
Patient
penetration
performed
Peripheral blood
Peritoneal dialysis
phase
phenotype
phosphatase
phosphorus
Placebo
placebo-controlled
Platelet
Platelet count
platelet distribution width
Platelets
Potassium
prealbumin
pregnancy test
pregnant
pressure
Primary outcome
Protein
protocol
random
randomisation
randomization
Randomized
Randomized controlled trial
receive
receiving
recruitment
red blood cell
red blood cells
renal
renal insufficiency
renal replacement therapy
Renmin Hospital
replacement therapy
required
researcher
respiratory
respiratory distress
respiratory infection
respiratory rate
Safety
Saline
saline solution
Sample size
SARS-CoV-2
secondary
Secondary outcomes
serious COVID-19
serum
serum amyloid
severe liver condition
severe pneumonia
single-cell analyses
sodium
specific gravity
Standard deviation
status
stem cell
study period
Study protocol
sugar
syphilis
Systolic blood pressure
T lymphocyte
Th1 cytokine
Th1 cytokines
Th2 cytokine
Th2 cytokines
therapeutic effect
therapeutic effects
time
TNF-a
Total
total bilirubin
Total cholesterol
total protein
traits
Transferrin
treat
Treatment
treatment for COVID-19
triacylglycerol
Trial
triple blinded
TTCI
Tuberculosis
Twenty participant
Twenty participants
university
urea
uric acid
Urine
urobilinogen
Variation
Version
vital signs
Volume
website
White blood cells
with HIV
within 6 months
women
World Health Organization
Wuhan
γ-glutamyl transferase
[DOI] 10.1186/s13063-020-04380-5 PMC 바로가기 [Article Type] Letter
[DOI] 10.1186/s13063-020-04380-5 PMC 바로가기 [Article Type] Letter